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ABSTRACT
 مييقت لجأ نم وه ةساردلا هذه نم يسيئرلا فدهلا :فادهلأا
 ءزلجاو سنوليفارج اتورل  لماكلا صلختسلما زيكرتلا -دامتعا راثآ
.ةيفيظولاو ةيدقعلا ةيساسلأا صاولخا ىلع اهنم ىقنلما يولقلا
 فودوقنلا ةقيرط انمدختسا ،ةرضاح ةيبيرتج ةسارد يف :ةقيرطلا
 تازيكرتلا  راثآ  ديدتح  لجا  نم  لوزعلما  ذرلجا  بلقل  بيرستلل
 يبلاقتسلإا نجيف صلختسلم ةفلتخلما
(1.25×10-6%  weight per volume percent [W/V]; 
2.5×10-6 % W/V; 3.75×10-6 % W/V) and total alkaloid 
of Rue (0.25×10-6 % W/V; 0.5×10-6 % W/V)
 تم  .بلقلا  جيسنل  ةيجولويسفلا  ةيئابرهكلا  صاولخا  ىلع  
 ةيطغتلا  ةيللاقتسا  سايقل  يرايتخلاا  زيفحتلا  تاءارجإ  لامعتسا
 انلمعتسا  .داهجلإاو  ليهستلاو   ةينايرشلا  ةيديرولا  ةيدقعلا
 ةيديرولا  ةيدقعلا  تادادعلإل  (N=24)  تاعومجم  ثلاث
 صلختسملل  ريثأتلا لوخد لجا نم لوزعلما ذرلجا بلقل ةينايرشلا
 ةيجولويسفلا لمعبم م2006 ربوتكأ يف ةساردلا تيرجأ .نجيف
 ةعماجب  ثاحبلأا  زكرمو  يئاعولا  يبلقلا  زاهجلل  ةيئابرهكلا
.ةيحصلا مولعلل ناتسلوج
 ةتبنلا  صلختسم  نم  لاك  ىدل  نأ  انجئاتن  ترهظأ  :جئاتنلا
 ىلع ةهباشتم تلاعافت سنوليفارج اتورل يولقلا ءزلجاو لماكلا
 ةبقاربم انمق كلذ نم ديزلما .لعافتلاو يدقعلا ديشرتلا تقو
 (83±4to 108±5 msec) (157.6±3to 163.7±4 msec)
ل ىصقلأا زيكرتلا دنع
3.75×10-6 % W/V
 بلقلا  تابرض ماظتنا  داضم رثأ  ىلا  هلاعأ  جئاتنلا  ريشت  :ةتماخ
 بلقلا  تابرض  عرست  قوف  جلاع  يف  سنوليفارج  اتورل  يلاثلما
.ينيطبلا يماظنلالا
Objectives: To evaluate concentration-dependent 
effects of total extract of Ruta graveolens and its 
purified alkaloid fraction on the nodal basic and 
functional properties.
Methods: In the present experimental study, we used 
the Langendorff model for perfusion of isolated rat 
hearts to determine the effects of various concentrations 
of methanolic extract of Rue (1.25×10-6 % weight per 
volume percent [W/V]; 2.5×10-6 % W/V; 3.75×10-6 
% W/V) and total alkaloid of Rue (0.25×10-6 % W/V; 
0.5×10-6 % W/V) on electrophysiological properties 
of cardiac tissue. Selective stimulation protocols were 
used to independently quantify atrioventricular (AV) 
nodal recovery, facilitation, and fatigue. We used 
3 groups (N=24) of isolated perfused rat AV nodal 
preparations to assess the effect of Rue extracts. 
The study was carried out in October 2006 in the 
electrophysiology laboratory of the Cardiovascular 
Research Center of Golestan University of Medical 
Sciences, Golestan, Gorgan, Iran.
Results: Our results showed that both the total plant 
extract and the alkaloid fraction of Ruta graveolens had 
a similar trend of action on nodal conduction time and 
refractoriness. Furthermore, we observed increased 
atrioventricular conduction time (83±4 to 108±5 
msec) and functional refractory period (157.6±3 
to 163.7±4 msec) at a maximum concentration of 
3.75×10-6 % W/V.
Conclusion: The above results indicated a potential 
antiarrhythmic effect of Ruta graveolens in treating 
supra ventricular tachyarrhythmia.
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Herbal remedies are suitable alternatives for synthetic drugs due to their availability, minimal 
side effects, and lower price.1 Several botanicals, 
including Crataegus oxyacantha and Digitalis purpura, 
have proven therapeutically beneficial for the treatment 
of cardiovascular disease. Herbal treatments have been 
used in patients with congestive heart failure, systolic 
hypertension, angina pectoris, atherosclerosis, cerebral 
insufficiency, venous insufficiency, and arrhythmia.2 Ruta 
graveolens L. (Rutaceae), a plant well known as (Rue) 
“syn”, is a sturdy shrub between 30-80 cm in height 
with a woody root and a crooked, branched rhizome. 
The leaves of this plant are 4-11 cm long and 3-7 cm 
wide. The plant is native to Northern Asia, the Southern 
Alps and France.3 The most important compounds of R. 
graveolens are rutin (Flavonoids), acridine, quinazoline, 
quinoline (alkaloids), hydroxycoumarine, lignans, and 
pyranocoumarins, and the methanolic extract of Rue is 
known to possess water-soluble glycosides Cnidioside.3-5 
Previous reports have demonstrated that Ruta graveolens 
(R. graveolens) has positive chronotropic and inotropic 
effects on the isolated right atria of normotensive rats, 
however, the substances responsible for the observed 
effect on the cardiovascular system have not been 
identified.6 Other reports have investigated the effects 
of R. graveolens on ionic currents and potassium (K+) 
depolarization in intact myelinated nerve fibers. Results 
of these experiments showed that the plant extract was 
able to block K+-current. The plant was also able to block 
Na+- current, although to a lesser extent.7 Additionally, 
lignans of R. graveolens have previously been shown to 
possess calcium (Ca2+) channel blocking activity.8 In 
the present study, we investigated the effect of the total 
extract of R. graveolens and its purified alkaloid fraction 
on AV nodal conduction time and refractoriness.
Methods. The study was carried out in October 2006 
in the electrophysiology laboratory of the Cardiovascular 
Research Center of Golestan University of Medical 
Sciences, Golestan, Gorgan, Iran. The aerial parts of 
R. graveolens were collected from a botanical garden 
in Kandelos, a region in the Mazandaran province of 
Iran. The plant materials were taxonomically identified 
and authenticated by the University of Mazandaran, 
Iran. A voucher specimen (3-67-3) was deposited at 
the herbarium of the Department of Pharmacognosy, 
Faculty of Pharmacy, Mazandaran University of 
Medical Sciences. Air-dried powder (700 g) from 
leaves of R. graveolens was extracted by percolation at 
room temperature with 70% ethanol. The extract was 
concentrated at 40ºC in a rotary vacuum evaporator to 
yield a gelatinous material. The extract was dissolved 
in distilled water and filtered. The filtrate was then 
evaporated to dry. The dried mass weighed 182 g (26%) 
and was diluted with Tyrode’s solution on the day of 
the experiments. Total alkaloids are largely extractable 
with chloroform from an alkaline solution. Briefly, 
the extracted fluid was acidified with 2N hydrochloric 
acid (HCl) and heated in a water bath. After cooling, 
aqueous ammonia was added to bring the extract 
to pH 10, at which point an alkaline reaction was 
initiated and a chloroform extraction was performed. 
The organic solvent was evaporated over a water bath, 
and the residue was absorbed with 20 ml of 2N HCl. 
The dried extract was first reconstituted in 70% ethanol 
and then tested by standard phytochemical methods9 
for the presence of alkaloids, flavonoids, saponin, 
tannin, and glycosides. Chemical screening was then 
performed to elucidate the composition of the extract. 
Dragendorff’s reagent (potassium bismuth iodide) was 
used to screen for alkaloids, magnesium (Mg2+) and 
HCl for flavonoids, and the ability to produce foam 
for saponins. The presence of tannin and glycosides in 
the extract was also determined using ferric chloride 
and Ninhydrin reagent. Verapamil was purchased 
from Sigma (St. Louis, Missouri, United States of 
America [USA]). Tyrode’s materials and reagents for 
phytochemical analysis were purchased from E. Merck 
(Darmstadt, Germany). Sodium heparin was purchased 
from B. Braun Medical S.A. (Spain). All drugs were first 
dissolved in distilled water at the time of the experiments 
and then diluted in the Tyrode’s solution at the final 
concentration described in the text. 
Animals. Male Sprague-Dawley rats (250-350g) 
from the Institute Pasteur of Iran were injected 
intraperitoneally with 2500 units of sodium heparin 
and then anesthetized with sodium pentobarbital (40 
mg/kg). The animals were housed in standard cages 
with free access to food and water. The vivarium 
temperature was maintained at 23±3ºC with a 12 hour 
light/dark cycle (light on from 06:00 to 18:00 hours). 
All trials were conducted in accordance with ethical 
guidelines for the investigation of experimental animals 
of Golestan University of Medical Sciences. Rat chest 
cavities were opened with a midsternal incision. The 
heart was quickly removed and placed in cold perfusion 
fluid under artificial respiration (REPIRATOR 
NARCO BIOSYSTEM, USA). The aorta was 
cannulated and retrogradely perfused with Tyrode’s 
solution of the following composition (g/l): sodium 
chloride (NaCl), 8.0, potassium chloride (KCl), 0.075, 
calcium chloride (CaCl2) 0.1, sodium bisulfite NaHO3, 
Disclosure. The authors declare no conflicts of 
interest directly relevant to the content of this 
study.
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0.05, and dextrose, 1.0. The perfusion had a pH of 
7.35 when equilibrated with a 95% O2, 5% CO2 gas 
mixture and was maintained at 37.5°C. The perfusion 
was controlled by maintaining a constant perfusion 
pressure of 68±2 mm Hg, resulting in a coronary flow 
of 9-12 ml/min. Local electrograms were obtained 
using bipolar, Teflon coated silver electrodes (diameter 
0.25 mm, interelectrode distance 0.25 mm (A-M 
Systems, US). They were placed near the sinus node 
and on the right ventricle. Preparations were stimulated 
through bipolar platinum–iridium electrodes (A-M 
Systems, US), placed on the right atrium close to the 
sinus node region. Stimulation protocols were executed 
using custom-made software running on a computer 
interfaced with an analog to digital converter. The heart 
was stimulated with isolated constant-current square 
wave pulses, 0.4 ms duration, with the stimulus current 
adjusted to twice diastolic threshold (WPI, A365, USA). 
Amplification and readouts of the electrograms were 
provided by polygraph (Power Lab, ML870, Australia) 
with a bandwidth of 30 Hz-3 KHz. Verapamil was used 
as a standard negative dromotropic drug to assess the 
relative efficacy of the plant. The extract and verapamil 
were first dissolved in distilled water and then diluted 
in the Tyrode’s solution at the final concentrations 
described in the text. Three groups of experiments were 
performed as follows: Experiment A (n=8) evaluated 
the effect of the methanolic extract of Rue (1.25, 2.5, 
3.8×10-6% W/V) on electrophysiological properties of 
AV-node. Experiment B (n=8) assessed the effect of 
different concentrations of the alkaloids fraction of the 
extract (0.25, 0.5 mg% W/V) on electrophysiological 
properties of the AV-node. Experiment C (n=8) 
investigated the role of the Ca2+ channel blocker, 
verapamil (0.1µM), on the electrophysiological 
properties of AN-node. The stimulation protocols were 
carried out during control conditions (no intervention) 
and in the presence of various concentrations of extract. 
Control measurements were collected in the presence 
of Tyrode’s solution. Different concentrations of Rue 
extract were then added to the superfusion solutions 
and the same stimulation protocols were repeated after 
15 minutes. Preparations were allowed to equilibrate in 
Tyrode’s solution for 30 minutes and were stimulated 
at basic cycle length (BCL) before the protocols were 
initiated. Only those preparations that maintained stable 
AV nodal conduction and Wenckebach cycle length 
(WBCL) during this time were used. The spontaneous 
mean sinus cycle length at the start of the experiments 
was 220±30 ms. The BCL was 20% shorter than sinus 
cycle length, and the mean basic conduction time 
(AVCT) was 67±5 ms. Specific stimulation protocols 
were used to quantify recovery and atrioventricular 
conduction time, as previously described.10 The WBCL 
(Wenckebach) was determined under control conditions 
by decreasing the atrial pacing cycle length by 10 ms 
decrements every 10 beats until a second degree AV 
block occurred. This protocol was performed before and 
after each experimental protocol to ensure the stability 
of WBCL. The AVCT was measured from the first rapid 
atrial activation in the atrial electrogram until the second 
deflection of the ventricle electrogram. The functional 
and effective refractory period of the AV node (FRP and 
ERP) were measured using an extrastimulus technique. 
The FRP was defined as the shortest V1V2 output 
interval resulting from premature atrial stimulation and 
ERP was defined as the longest A1A2 interval activating 
the atrial septum close to the AV node but failing to 
propagate through the ventricle. Specific stimulation 
protocols were used as previously described.10 Briefly, 
AV-nodal recovery refers to the slow and progressive 
recovery of excitability that causes the nodal conduction 
time (NCT) to increase prematurely. To construct the 
basic recovery curve, a signal premature of delayed 
stimulus (S2) was introduced after every 10 basic stimuli 
(S1). The relationship between the conduction time of 
the test beat (A2V2) and the preceding recovery time 
(V1A2) was established and fitted to an exponential 
function as previously described.10
Results. Phytochemical analysis. Preliminary 
phytochemical analysis of the methanolic extract of R. 
Figure 1 - Stimulation protocols used to quantify atrioventricular (AV) 
nodal recovery, wenckebach cycle length (WBCL), effective 
and functional refractory period (ERP and FRP). S1 - 
represents basic stimuli; Sn (2,3,4,5,…) test stimuli used to 
assess the AV behavior, A - atrial, H - his bundle, V - ventricular 
conduction. Effective refractory period; Minimum AA during 
continuous atrial stimulation (A4A3), Functional refractory 
period; Minimum VV during continuous atrial stimulation.
Block conduction.
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Figure 3 - Plots of effects of different concentration of total methanolic 
extract of Ruta graveolens (R. graveolens) on recovery curve, in one 
rat heart preparation. R. graveolens shifted recovery curve upward 
in a dose-dependent fashion. Three different concentration of R. 
graveolens (Rue): Rue 1 - 1.25×10-6 % W/V, Rue 2 - 2.5×10-6 
% W/V, Rue 3 - 3.75×10-6 % W/V, Con - control,  A2V2 - 
conduction time, V1A2 - recovery time, msec - miliseconds.
Figure 4 - Plots of the effects of different concentration of total alkaloid 
extract of Ruta graveolens (R. graveolens) on recovery curve in a 
one rat heart preparation. R. graveolens shifted recovery curve 
upward in a dose dependent fashion. R. graveolens (Rue G, 
Alk 0.25×10-6 % W/V), (Rue G, Alk 0.5×10-6%W/V), A2V2 
- conduction time, V1A2 - recovery time, msec - miliseconds.
Figure 2 - Bar graph of  the effects of total methanolic 
extract of Ruta graveolens (R. graveolens) at 
various concentrations and verapamil (0.1 µM) 
(Experiments=7) on a) atrioventricular conduction 
time (AVCT), b) Wenckebach cycle length (WBCL), 
and c) effective refractory period (ERP). Ruta 
graveolens and verapamil prolonged Tonic properties 
of AV node (ERP, AVCT, WBCL), R. graveolens (Rue 
1), 1.25×10-6 % W/V, (Rue 2), 2.5×10-6 % W/V, 
(Rue 3), 3.75×10-6 % W/V, Ver - Verapamil, Con - 
control, ms - miliseconds. Results are shown as Mean 
± SE (* p≤0.05, ** p≤0.01, *** p≤0.001 significantly 
different from control values). p<0.05 considered 
significant, p<0.01 considered very significant, 
p<0.001 considered extremely significant.
graveolens leaves revealed the presence of alkaloids (+++), 
flavonoids (+), and saponins (+). In contrast, tannins 
and glycosides were absent from the methanolic extract 
(Figures1 & 4). 
Electrophysiological effects of total and alkaloid 
fraction of methanolic extract of R. graveolens on 
isolated heart. The addition of the extract to the 
experimental system increased WBCL, AV-conduction 
time, and effective and functional refractory periods in 
a concentration-dependent manner (Figure 2). Figure 3 
illustrates an example of a basic nodal recovery curve 
for one rats isolated heart preparation. The extract 
causes the basic recovery curve to shift upward in a 
dose-dependent fashion. At concentrations of 1.25×10-
5 (w/v) and 2.5×10-6 (w/v) the extract increased the 
time constant of recovery from 40.8±5 ms (control) 
a
b
c
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Table 1 -	 Values of constants characterizing recovery in the presence of 
total extract of Ruta graveolens (R. graveolens).
Variables Mean±SE P-value
τ (ms)
Con 40.8±5
Rue 1      48.9±10.4 0.1
Rue 2    38±6 0.2
Rue 3    40.2±4.2 0.1
β (ms)
Con    240.4±30.5
Rue 1    310±28 0.05
Rue 2 377.7±66 0.01
Rue 3 974.4±90 0.05
The effects of various concentration of methanolic extract of R. graveolens 
on recovery parameters (τ and β are constants of recovery protocol). Rue 
- R. graveolens: Rue 1 - 1.25×10-6 % W/V, Rue 2 - 2.5×10-6 % W/V, Rue 
3 - 3.75×10-6 % W/V, ms - miliseconds, Con - control. Results are shown 
as Mean ± SE (Experiments = 8). τ - time constant of the slop of recovery 
curve, β - maximum atrioventricular conduction time, p<0.05 considered 
significant as compared with control, p<0.01 considered very significant 
as compared with control, p<0.005 considered extremely significant as 
compared with control
Table 2 - Values of constants characterizing basic properties of hearts in 
the presence of Ruta graveolens (R. graveolens) alkaloids. 
Variable Mean±SE P-value
WBCL (ms)
Con 153.3±2.1
Alk1 168.2±6.2 ≤0.05
Alk2 180.4±4.3 ≤0.01
AVCT (ms)
Con   64.2±5.7
Alk1   76.6±5.1 ≤0.01
Alk2   92.3±6.5 ≤0.01
ERP (ms)
Con 120.8±6.5
Alk1 140.8±6.0 ≤0.05
Alk2 150.0±4.0 ≤0.05
FRP (ms)
Con 154.6±8.4
Alk1 175.0±9.0 ≤0.05
Alk2   205.5±11.2 ≤0.01
The effects of total alkaloid of R. graveolens at various concentrations 
(Experiments=8) on effective and functional refractory period (ERP and 
FRP), AVCT - atrioventricular conduction time, WBCL - Wenckebach 
cycle length, R. graveolens prolonged tonic properties of AV node. Results 
are shown as Mean±SE: Alk1 ( 0.25×10
-6 % W/V), Alk2 (0.5×10
-6 % W/V), 
Con - control, Alk - alkaloids of R. graveolens, ms - miliseconds, 
p<0.05 considered significant from control values,
p<0.01 considered very significant from control values
Table 3 - Values of constants characterizing recovery in the presence of 
Ruta graveolens (R. graveolens) alkaloids. 
Variable Mean±SE P-value
τ
Con 30.3±5.0
Alk1 30.0±1.1 ≤1.1
Alk2 32.2±9.5 ≤0.2
β
Con 339.0±114.1
Alk1 429.2±120.6 ≤0.01
Alk2 550.1±-90.1 ≤0.05
The effects of different concentrations of total alkaloid (Alk) extract of 
R. graveolens on recovery parameters (τ and β are constants of recovery 
protocol). Results are shown as Mean±SE (Experiments=8). 
P<0.05 considered significant, R. graveolens Alk1 (0.25×10
-6 % W/V),
R. graveolens Alk2, 0.5×10
-6% W/V, Con - control, τ - time constant of the 
slop of recovery curve, β - maximum AV conduction time
to 48.9±10.4 ms and 38±6 ms (Table 1). The effects of 
the alkaloid fraction on the basic (AVCT, Wenckebach, 
ERP, FRP) and functional (recovery protocol) 
characteristics of perfused hearts are demonstrated in 
Table 2. The effects of this fraction on the recovery curve 
were similar to those observed with the total extract. 
However, low concentrations (0.25 mg W/V %) of 
the alkaloid fraction also induced a nonsignificant 
prolongation of the recovery curve parameters. These 
parameters were increased to significant levels following 
exposure to high concentrations (0.5 mg W/V %) of 
the alkaloid fraction (Table 3). Addition of the positive 
control, verapamil (0.1µM), to the perfusion solution 
increased Wenckebach, EFP, FRP, and AVCT (Figure 
2). With the exception of the prolonged recovery curve 
parameters, verapamil exerted similar effects on basic 
and rate dependent properties of the AV node to those 
observed following the addition of the total extract and 
the alkaloid fraction. 
Discussion. The present study was designed 
to evaluate the effects of R. graveolens (Rue) on the 
electrophysiological properties of isolated heart, with 
particularly attention to its effect on the rate dependent 
properties of the AV-node. Our study showed that 
extract isolated from R. graveolens depressed the basic 
and functional properties of isolated heart and that 
these actions were ascribed to the alkaloid fraction. The 
wide variety of delays that the AV-node can generate in 
response to an increased rate are explained by dynamic 
interactions among the 3 intrinsic properties of recovery, 
facilitation, and fatigue.11 To date, numerous studies 
have examined the effects of autonomic, purinergic, 
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and some pharmacological interventions on nodal 
functional properties in detail.11,12,13 Ruta graveolens 
caused a dose-dependent increase in atrioventricular 
conduction time, Wenckebach, and the functional 
and effective nodal refractory periods. These results 
on the electrophysiological parameters of isolated rat 
heart preparation were similar to those observed after 
the addition of verapamil. The Ca2+-blockers have 
been shown to suppress basic and functional properties 
of AV- nodal cells due to a selective inhibition of the 
slow inward Ca2+ current.14 Our results showed that 
R. graveolens also suppressed nodal properties with an 
efficacy smaller to that of verapamil. A previous study 
also demonstrated the Ca2+-inhibitory activity of R. 
graveolens, therefore, compounds found in this plant 
may be assumed to modulate the slow inward Ca2+-
current for nodal cells.8 The mechanisms underlying 
rate-dependent AV nodal properties have not yet been 
fully elucidated.15 It is possible that the time dependent 
recovery of Ca2+ channels from in activation plays 
a major role in determining the AV-node curve.16 
Hashino13 proposed that at least IK and ICaL are involved 
in the rate-dependent recovery of excitability of AV 
nodal cells. When nodal function is represented with 
a recovery curve (premature Atrial-His interval versus 
cycle length), the fast pathway (based on compact 
node) accounts for atrial-His intervals observed at long 
and intermediate cycle lengths. During anterograde 
conduction, the premature impulses travel through fast 
and slow pathways in the flat and steep portions of the 
nodal curve. Ablation of the posterior extension (slow 
pathway) removes the left steep rise of the anterograde 
curve, thus prolonging effective nodal refractory period 
and shortening nodal conduction time maximum 
without changing the curve baseline.17 The present 
findings indicated that both the flat and steep rising 
portions of the nodal recovery curve are affected by 
R. graveolens. An upward shift in the baseline of the 
nodal recovery curve may therefore reflect the presence 
of depressed slow and fast pathways and support a 
potential role for R. graveolens in both pathway and in 
re-entry. 
We demonstrated that verapamil had more 
pronounced effects on nodal conduction time and 
refractory period compared with R. graveolens. 
Nodal refractoriness determines the minimum cycle 
length, which ventricles may be activated, and can 
thereby determine cardiac function in the presence of 
supraventricular tachyarrhythmia. Three indices of nodal 
refractoriness have been developed: effective, functional 
refractory periods, and Wenckebach. Our results showed 
that R. graveolens significantly prolonged effective 
and functional refractory periods in a rate dependent 
manner. Billette18 has shown that ERP and FRP 
originated in the proximal and distal nodes. However, 
the degree of refractoriness can be modulated by the 
contribution of INa, If, or ICaT. This may be expected to 
contribute to a variable extent among the different cell 
types in the AV node.15 Therefore, agents that increases 
AV nodal refractoriness, such as R. graveolens, would be 
expected to modulate the ionic currents responsible for 
AV nodal refractoriness (INa, If or ICaT). Previous studies 
have shown that R. graveolens possessed K+ and Na+ 
inhibitory activities, thus confirming the depressant 
effects of this plant on refractoriness.7 
Results from our preliminary phytochemical analysis 
shows the presence of alkaloids, flavonoids, and saponins 
in the leaf extract. Many plant-derived compounds 
are known to affect calcium channels.19 For example, 
several alkaloids were shown to possess Ca2+, Na+ and 
K+ blocker activities.20,21 Previous studies have identified 
several quinoline, quinazoline, and acridine alkaloids in 
the R. graveolens extract.3 The results of the present study 
showed that the alkaloid extract of R. graveolens had a 
similar activity to the total leaf extract. Therefore, it 
seems that depressant effects of this plant on functional 
and basic properties of the heart are likely to be ascribed 
to these components present in the leaves. The Ca2+- 
antagonists, such as verapamil, are highly effective in the 
treatment of proximal supraventricular tachycardia.22 
Therefore, R. graveolens may be beneficial in the 
treatment of proximal supraventricular tachycardia.
In the present study, although there are significant 
changes in the basic and rate-dependent properties of 
the AV-node by this plant, we never considered the 
potential anti-arrhythmic role of the R. graveolens in 
an in-vivo experimental animal model, also the exact 
cellular mechanism of the plant on the ionic channels of 
the transitional and compact nodal cells of the AV-node 
have not been determined. Further studies need to be 
carried out to clarify these mechanisms.
In conclusion, we have shown that R. graveolens 
alters the functional and basic properties of the AV-node 
in isolated heart preparations. These changes result in 
slowed AV-node conduction and prolongation of nodal 
refractoriness. Furthermore, our results indicate that 
the alkaloid fraction is likely to be responsible for these 
actions.
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